Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Other1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT06958939Phase 1Active Not Recruiting
The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis
Myasthenia Gravis, Generalized
StudychairStart date: 2025-05-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

The Second Affiliated Hospital of Air Force Military Medical University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Wen Xu

The First Affiliated Hospital of University of Science and Technology of China

Moderately Similar
1 trials

Shared therapeutic areas:

Myasthenia Gravis, Generalized
Similarity Score30%

Momenta General Queries

Momenta Pharmaceuticals, Inc.

Moderately Similar
2 trials

Shared therapeutic areas:

Myasthenia Gravis, Generalized
Similarity Score30%

Kristina M Kelly, DPT

University of Missouri-Columbia

Moderately Similar
1 trials

Shared therapeutic areas:

Myasthenia Gravis, Generalized
Similarity Score30%

Vera Bril, MD

Toronto General Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Myasthenia Gravis, Generalized
Similarity Score30%

Ting Chang, MD,PHD

The Second Affiliated Hospital of Air Force Military Medical University

Moderately Similar
1 trials

Shared therapeutic areas:

Myasthenia Gravis, Generalized
Similarity Score30%

Raffaele Iorio

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Moderately Similar
5 trials

Shared therapeutic areas:

Myasthenia Gravis, Generalized
Similarity Score30%

Antonio Guglietta, MD

argenx

Moderately Similar
3 trials

Shared therapeutic areas:

Myasthenia Gravis, Generalized
Similarity Score30%

Megan L Fitzgerald, PhD

Brain Inflammation Collaborative

Moderately Similar
1 trials

Shared therapeutic areas:

Myasthenia Gravis, Generalized
Similarity Score30%

Sabine Coppieters, MD

argenx

Moderately Similar
1 trials

Shared therapeutic areas:

Myasthenia Gravis, Generalized
Similarity Score30%

Rudy Mercelis, MD, PhD

University Hospital, Antwerp

Moderately Similar
2 trials

Shared therapeutic areas:

Myasthenia Gravis, Generalized
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06958939Phase 1StudyChair

The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis

Myasthenia Gravis, Generalized
Active Not Recruiting

All 1 trials loaded